CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 137 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,180,000 | -51.0% | 29,580 | -43.3% | 0.02% | -45.7% |
Q3 2016 | $6,496,000 | -5.4% | 52,185 | -19.2% | 0.05% | -4.2% |
Q2 2016 | $6,867,000 | +37.5% | 64,585 | +48.0% | 0.05% | +45.5% |
Q1 2016 | $4,995,000 | -19.6% | 43,630 | 0.0% | 0.03% | -15.4% |
Q4 2015 | $6,216,000 | +59.6% | 43,630 | +0.6% | 0.04% | +44.4% |
Q3 2015 | $3,895,000 | – | 43,360 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
Kylin Management | 188,226 | $21,676,000 | 2.36% |
Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |